Clinical Trials Directory

Trials / Completed

CompletedNCT05567874

Nosocomial COVID-19 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

Proportion of Nosocomial COVID-19 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

Status
Completed
Phase
Study type
Observational
Enrollment
216 (actual)
Sponsor
Centre Hospitalier Régional Metz-Thionville · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The rate of nosocomial SARS-CoV2 infections found in the different studies since the beginning of the pandemic is very variable (\<1% in hospitals in the USA to about 20% in a British hospital). Mortality related to these nosocomial SARS-CoV2 infections is higher than in the general population. The risk factors identified for this nosocomial acquisition are multiple. We were confronted with nosocomial acquisitions and cluster situations in the services, without exhaustive data to measure these phenomena, and we lacked data to consider areas for improvement. The objectives of this study are to determine the proportion of nosocomial SARS COV 2 infections in the total number of patients hospitalized with a Covid-19 infection at the CHR Metz-Thionville in 2021, and to describe the characteristics of this population.

Conditions

Interventions

TypeNameDescription
OTHERNosocomial SARS-COV 2 Infection proportionProportion of Nosocomial SARS-COV 2 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

Timeline

Start date
2022-01-03
Primary completion
2022-03-31
Completion
2022-08-31
First posted
2022-10-05
Last updated
2023-05-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05567874. Inclusion in this directory is not an endorsement.